The IMPACCT: mHealth in Clinical Trials series provides a dedicated forum for industry leaders in clinical and digital innovation to share data, best practice and game-changing approaches on how to transform the clinical research paradigm with digital technology and achieve true patient-centricity.

Join your peers and leading experts in this space for a collaborative discussion aiming to tackle key implementation challenges and accelerate the successful incorporation of innovative digital strategies in clinical R&D, to enhance patient experience and outcomes.

Industry leaders already confirmed include Novartis, AbbVie, the DiMe Society, Verily & many others.